Document Detail


A20: from ubiquitin editing to tumour suppression.
MedLine Citation:
PMID:  20383180     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Clinicians have suspected for hundreds of years that chronic activation of the immune system contributes to the development of cancer. However, the molecular mechanisms that mediate this precarious interplay are only now being elucidated. Recent reports have identified A20 as a crucial tumour suppressor in various lymphomas. A20 is a ubiquitin-editing enzyme that attenuates the activity of proximal signalling complexes at pro-inflammatory receptors. In this Review we summarize the evidence linking chronic inflammation with tumorigenesis and consider how A20 modulates inflammatory signalling cascades, thereby providing a mechanism to explain how deregulation of ubiquitylation can promote tumorigenesis.
Authors:
Sarah G Hymowitz; Ingrid E Wertz
Publication Detail:
Type:  Journal Article; Review     Date:  2010-04-12
Journal Detail:
Title:  Nature reviews. Cancer     Volume:  10     ISSN:  1474-1768     ISO Abbreviation:  Nat. Rev. Cancer     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-04-23     Completed Date:  2010-05-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101124168     Medline TA:  Nat Rev Cancer     Country:  England    
Other Details:
Languages:  eng     Pagination:  332-41     Citation Subset:  IM    
Affiliation:
Department of Structural Biology, Genentech, Inc.1 DNA Way, M/S 40, South San Francisco, CA 94080, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Genes, Tumor Suppressor
Humans
Inflammation / genetics,  metabolism
Intracellular Signaling Peptides and Proteins / metabolism*
NF-kappa B / genetics,  metabolism
Neoplasms / genetics,  metabolism*
Nuclear Proteins / metabolism*
Signal Transduction / physiology*
Ubiquitin / metabolism*
Ubiquitination / physiology
Chemical
Reg. No./Substance:
0/Intracellular Signaling Peptides and Proteins; 0/NF-kappa B; 0/Nuclear Proteins; 0/Ubiquitin; EC 6.3.2.19/TNFAIP3 protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer.
Next Document:  Treatment options for male stress urinary incontinence.